Body

Common genetic mutation increases sodium retention, blood pressure

AUGUSTA, Ga. – Nearly 40 percent of the small adrenal tumors that cause big problems with high blood pressure share a genetic mutation that causes patients to retain too much sodium, researchers report.

The study of 47 human, benign adrenal gland tumors also showed a mutation of the gene KCNJ5 is twice as likely to occur in women – 71 versus 29 percent – as it points to potential new treatments for some patients who don't respond to current hypertension regimens, said Dr. William E. Rainey, Scientific Director of the Adrenal Center at Georgia Health Sciences University.

21st century bloodletting reduces cardiovascular risk

It seems that while the practice of bloodletting throughout history had little or no effect on most diseases, and the practice was abandoned in the 19th century, new research published in BioMed Central's open access journal BMC Medicine demonstrates that blood donation has real benefits for obese people with metabolic syndrome. Two sessions of bloodletting were enough to improve blood pressure and markers of cardiovascular disease.

Blocking LRRK2 activity is not a simple answer to Parkinson's disease

Mutations in the LRRK2 gene are the most common cause of genetic Parkinson's disease (PD). New research published in BioMed Central's open access journal Molecular Neurodegeneration demonstrates that loss of function of LRRK2 (by deletion of the kinase domain) leads to changes in motor co-ordination and causes anxiety-like behaviors and kidney degeneration in mice without affecting dopamine-mediated brain activity.

Female fat prejudice persists even after weight loss, study finds

Overweight women may never escape the painful stigma of obesity – even after they have shed the pounds, new research suggests.

The study, by the University of Hawaii at Mānoa, The University of Manchester, and Monash University, examined whether anti-fat prejudice against women persisted even after they had lost significant weight and were now thin.

New PLoS Medicine series will focus on best practice in global mental health

A new series on the best ways to help people with mental health problems around the world is launched in this week's PLoS Medicine.

Writing in an editorial, the editors of PLoS Medicine together with key international mental health experts say: "Today we are delighted to announce the launch of the PLoS Medicine series on Global Mental Health Practice, and to issue a call for case studies that can help broaden our understanding of global mental health in "real-life" contexts."

New approach to screen pregnant women for mental health disorders

A new model of care for screening and treating women around the time of childbirth for mental health disorders shows promise according to researchers from South Africa reporting in this week's PLoS Medicine as part of the newly launched series in global mental health practice.

Safeguards against misuse of genetic data urged

Rapid advancements in genetic disease research necessitate innovative safeguards for patients, according to new American Heart Association policy recommendations published in Circulation, an American Heart Association journal.

Recent scientific progress includes the mapping of the entire human genetic code, or genome, which was completed in 2003, and new accelerated gene-sequencing techniques. These discoveries have led to cheaper, more readily available genetic tests, but regulations have lagged behind.

Nowhere to hide: New device sees bacteria behind the eardrum

CHAMPAIGN, lll. — Doctors can now get a peek behind the eardrum to better diagnose and treat chronic ear infections, thanks to a new medical imaging device invented by University of Illinois researchers. The device could usher in a new suite of non-invasive, 3-D diagnostic imaging tools for primary-care physicians.

The research team, led by University of Illinois electrical and computer engineering professor Stephen Boppart, will publish their advance in the online Early Edition of the journal Proceedings of the National Academy of Sciences the week of May 28.

Study reveals how the world's first drug for amyloid disease works

LA JOLLA, CA – May 29, 2012 – Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel®) works. Tafamidis, approved for use in Europe and currently under review by the US Food and Drug Administration (FDA), is the first medication approved by a major regulatory agency to treat an amyloid disease, a class of conditions that include Alzheimer's.

Chemical fingerprinting tracks the travels of little brown bats

They're tiny creatures with glossy, chocolate-brown hair, out-sized ears and wings. They gobble mosquitoes and other insect pests during the summer and hibernate in caves and mines when the weather turns cold. They are little brown bats, and a deadly disease called white-nose syndrome is threatening their very existence.

New drug strategy attacks resistant leukemia and lymphoma

BOSTON--Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.

John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting

Hackensack, New Jersey (May 29, 2012) – Physicians and researchers at John Theurer Cancer Center at HackensackUMC, one of the nation's top 50 cancer centers, will present the latest findings in blood-cancer research at the 2012 American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 1-5. Their involvement in these studies is part of John Theurer Cancer Center's continued focus to bolster its research program.

After 25 years, World No Tobacco Day is making an impact

May 31 marks the 25th anniversary of World No Tobacco Day, but does the day really inspire anyone to think about quitting smoking? Yes it does, according to a new study led by investigators from the Informatics Program at Children's Hospital Boston and Johns Hopkins Bloomberg School of Public Health. For the study, the research team monitored news promoting cessation and Internet search queries indicative of cessation for six years in seven Latin American nations.

GW researchers discover biomarker for advanced bile duct fibrosis and bile duct cancer

WASHINGTON (May 29, 2012) —GW Researchers, Jeffrey M.

Secure, sustainable funding for Indigenous participation in Arctic Council a key priority: Report

Finding a new way to fund the full participation of northern indigenous groups with Permanent Participant status at the Arctic Council in all of the organizations working groups and activities should be a top priority when Canada takes the chair of the influential inter-governmental organization next year.

The recommendation is one of 19 offered today by one of Canadas foremost initiatives on Arctic issues the Munk-Gordon Arctic Security Program to the Canadian government as it prepares to chair the Arctic Council in 2013.